abstract |
The use of compounds of formula (I), defined herein, or pharmaceutically acceptable saltsnthereof, or of pharmaceutically acceptable esters, ethers or N-alkylcarbamoyl derivatives ofncompounds of formula (Ia), defined herein, or phamaceutically acceptable salts thereof in thenmanufacture of a medicament for the treatment or prevention of a bacterial infection causednby Mycobacterium bacteria is disclosed. The invention further provides the use ofncapuramycin in the manufacture of a medicament for the treatment or prevention of anbacterial infection caused by Mycobacterium tuberculosis bacteria. |